{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:50:20Z","timestamp":1788382220655,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>Osteoporosis (OP) is a disease caused by multiple factors. Studies have pointed out that isopsoralen (IPRN) is one of the most effective drugs for the treatment of OP. Based on network pharmacological and molecular experimental analysis, the molecular mechanism of IPRN in osteoporosis is clarified.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>IPRN target genes and OP-related genes were predicted from the databases. Intersections were obtained and visualized. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed on target genes, which was confirmed by experiments internal and external experiments. Molecular docking was used to verify the binding between IPRN and target proteins. Molecular dynamics (MD) simulates the binding affinity of protein targets and active compounds.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>87 IPRN target genes and 242 disease-related targets were predicted. The protein\u2013protein interaction (PPI) network identified 18 IPRN target proteins for the treatment of OP. GO analysis indicated that target genes were involved in biological processes. KEGG analysis showed that pathways such as PI3K\/AKT\/mTOR were associated with OP. Cell experiments (qPCR and WB) found that the expressions of PI3K, AKT, and mTOR in MC3T3-E1 cells at 10\u00a0\u03bcM, 20\u00a0\u03bcM, and 50\u00a0\u03bcM IPRN concentrations, especially at 20\u00a0\u03bcM IPRN treatment, were higher than those in the control group at 48\u00a0h. Animal experiments also showed that compared with the control group, 40\u00a0mg\/kg\/time IPRN could promote the expression of the PI3K gene in chondrocytes of SD rats.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study predicted the target genes of IPRN in the treatment of OP and preliminarily verified that IPRN plays an anti-OP role through the PI3K\/AKT\/mTOR pathway, which provides a new drug for the treatment of OP.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13018-023-03689-6","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T04:05:12Z","timestamp":1681704312000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A study on the anti-osteoporosis mechanism of isopsoralen based on network pharmacology and molecular experiments"],"prefix":"10.1186","volume":"18","author":[{"given":"Jian","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruikun","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,17]]},"reference":[{"key":"3689_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.afos.2020.02.003","volume":"6","author":"L M\u00f6ckel","year":"2020","unstructured":"M\u00f6ckel L, Bartneck M, M\u00f6ckel C. Risk of falls in postmenopausal women treated with romosozumab: Preliminary indices from a meta-analysis of randomized, controlled trials. Osteoporosis Sarcopenia. 2020;6:20\u20136.","journal-title":"Osteoporosis Sarcopenia"},{"key":"3689_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/17512433.2021.1851192","volume":"14","author":"F Migliorini","year":"2021","unstructured":"Migliorini F, Colarossi G, Baroncini A, Eschweiler J, Tingart M, Maffulli N. Pharmacological management of postmenopausal osteoporosis: a level I evidence based\u2014expert opinion. Expert Rev Clin Pharmacol. 2021;14:105\u201319.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"3689_CR3","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.3390\/medicina57101119","volume":"57","author":"F Migliorini","year":"2021","unstructured":"Migliorini F, Giorgino R, Hildebrand F, Spiezia F, Peretti GM, Alessandri-Bonetti M, Eschweiler J, Maffulli N. Fragility fractures: risk factors and management in the elderly. Medicina (Kaunas). 2021;57:1119.","journal-title":"Medicina (Kaunas)"},{"key":"3689_CR4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/0960-0760(90)90497-9","volume":"37","author":"C Gennari","year":"1990","unstructured":"Gennari C, Agnusdei D. Calcitonin, estrogens and the bone. J Steroid Biochem Mol Biol. 1990;37:451\u20135.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"3689_CR5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1017\/S000711451000019X","volume":"104","author":"G Moschonis","year":"2010","unstructured":"Moschonis G, Katsaroli I, Lyritis GP, Manios Y. The effects of a 30-month dietary intervention on bone mineral density: the Postmenopausal Health Study. Br J Nutr. 2010;104:100\u20137.","journal-title":"Br J Nutr"},{"key":"3689_CR6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/bmb\/ldac017","volume":"143","author":"F Migliorini","year":"2022","unstructured":"Migliorini F, Colarossi G, Eschweiler J, Oliva F, Driessen A, Maffulli N. Antiresorptive treatments for corticosteroid-induced osteoporosis: a Bayesian network meta-analysis. Br Med Bull. 2022;143:46\u201356.","journal-title":"Br Med Bull"},{"key":"3689_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12891-020-03217-1","volume":"21","author":"KS Oumer","year":"2020","unstructured":"Oumer KS, Liu Y, Yu Q, Wu F, Yang S. Awareness of osteoporosis among 368 residents in China: a cross-sectional study. BMC Musculoskelet Disord. 2020;21:197.","journal-title":"BMC Musculoskelet Disord"},{"key":"3689_CR8","doi-asserted-by":"publisher","first-page":"e2121106","DOI":"10.1001\/jamanetworkopen.2021.21106","volume":"4","author":"L Wang","year":"2021","unstructured":"Wang L, Yu W, Yin X, Cui L, Tang S, Jiang N, Cui L, Zhao N, Lin Q, Chen L, Lin H, Jin X, Dong Z, Ren Z, Hou Z, Zhang Y, Zhong J, Cai S, Liu Y, Meng R, Deng Y, Ding X, Ma J, Xie Z, Shen L, Wu W, Zhang M, Ying Q, Zeng Y, Dong J, Cummings SR, Li Z, Xia W. Prevalence of osteoporosis and fracture in China: the China osteoporosis prevalence study. JAMA Netw Open. 2021;4:e2121106.","journal-title":"JAMA Netw Open"},{"key":"3689_CR9","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1186\/s13018-021-02678-x","volume":"16","author":"F Migliorini","year":"2021","unstructured":"Migliorini F, Maffulli N, Colarossi G, Eschweiler J, Tingart M, Betsch M. Effect of drugs on bone mineral density in postmenopausal osteoporosis: a Bayesian network meta-analysis. J Orthop Surg Res. 2021;16:533.","journal-title":"J Orthop Surg Res"},{"key":"3689_CR10","doi-asserted-by":"crossref","unstructured":"Osteoporosis prevention, diagnosis, and therapy. Jama. 2001;(285):785\u201395.","DOI":"10.1001\/jama.285.6.785"},{"key":"3689_CR11","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s13018-021-02497-0","volume":"16","author":"F Migliorini","year":"2021","unstructured":"Migliorini F, Maffulli N, Spiezia F, Peretti GM, Tingart M, Giorgino R. Potential of biomarkers during pharmacological therapy setting for postmenopausal osteoporosis: a systematic review. J Orthop Surg Res. 2021;16:351.","journal-title":"J Orthop Surg Res"},{"key":"3689_CR12","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s13018-021-02474-7","volume":"16","author":"F Migliorini","year":"2021","unstructured":"Migliorini F, Maffulli N, Spiezia F, Tingart M, Maria PG, Riccardo G. Biomarkers as therapy monitoring for postmenopausal osteoporosis: a systematic review. J Orthop Surg Res. 2021;16:318.","journal-title":"J Orthop Surg Res"},{"key":"3689_CR13","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.2174\/0929867327666200330142432","volume":"28","author":"H Li","year":"2021","unstructured":"Li H, Xiao Z, Quarles LD, Li W. Osteoporosis: mechanism, molecular target and current status on drug development. Curr Med Chem. 2021;28:1489\u2013507.","journal-title":"Curr Med Chem"},{"key":"3689_CR14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"JE Rossouw","year":"2002","unstructured":"Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial. JAMA. 2002;288:321\u201333.","journal-title":"JAMA"},{"key":"3689_CR15","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.pharmthera.2016.01.015","volume":"162","author":"IR Indran","year":"2016","unstructured":"Indran IR, Liang RL, Min TE, Yong EL. Preclinical studies and clinical evaluation of compounds from the genus Epimedium for osteoporosis and bone health. Pharmacol Ther. 2016;162:188\u2013205.","journal-title":"Pharmacol Ther"},{"key":"3689_CR16","doi-asserted-by":"publisher","first-page":"4362","DOI":"10.3390\/nu6104362","volume":"6","author":"DW Lim","year":"2014","unstructured":"Lim DW, Kim YT. Anti-osteoporotic effects of Angelica sinensis (Oliv.) Diels extract on ovariectomized rats and its oral toxicity in rats. Nutrients. 2014;6:4362\u201372.","journal-title":"Nutrients."},{"key":"3689_CR17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1142\/S0192415X14500104","volume":"42","author":"Y Pan","year":"2014","unstructured":"Pan Y, Niu Y, Li C, Zhai Y, Zhang R, Guo X, Mei Q. Du-zhong (Eucommia ulmoides) prevents disuse-induced osteoporosis in hind limb suspension rats. Am J Chin Med. 2014;42:143\u201355.","journal-title":"Am J Chin Med"},{"key":"3689_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1142\/S0192415X16500038","volume":"44","author":"X Zhang","year":"2016","unstructured":"Zhang X, Zhao W, Wang Y, Lu J, Chen X. The chemical constituents and bioactivities of Psoralea corylifolia Linn.: a review. Am J Chin Med. 2016;44:35\u201360.","journal-title":"Am J Chin Med."},{"key":"3689_CR19","doi-asserted-by":"publisher","first-page":"363052","DOI":"10.1093\/ecam\/nen087","volume":"2011","author":"Y Wang","year":"2011","unstructured":"Wang Y, Hong C, Zhou C, Xu D, Qu HB. Screening antitumor compounds psoralen and isopsoralen from Psoralea corylifolia L. seeds. Evid Based Complement Alternat Med. 2011;2011:363052.","journal-title":"Evid Based Complement Alternat Med"},{"key":"3689_CR20","doi-asserted-by":"publisher","first-page":"641","DOI":"10.4314\/ahs.v14i3.20","volume":"14","author":"H Lu","year":"2014","unstructured":"Lu H, Zhang L, Liu D, Tang P, Song F. Isolation and purification of psoralen and isopsoralen and their efficacy and safety in the treatment of osteosarcoma in nude rats. Afr Health Sci. 2014;14:641\u20137.","journal-title":"Afr Health Sci"},{"key":"3689_CR21","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.3390\/molecules23102600","volume":"23","author":"L Ge","year":"2018","unstructured":"Ge L, Cui Y, Cheng K, Han J. Isopsoralen enhanced osteogenesis by targeting AhR\/ER\u03b1. Molecules. 2018;23:2600.","journal-title":"Molecules"},{"key":"3689_CR22","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.bbrc.2011.01.021","volume":"405","author":"DZ Tang","year":"2011","unstructured":"Tang DZ, Yang F, Yang Z, Huang J, Shi Q, Chen D, Wang YJ. Psoralen stimulates osteoblast differentiation through activation of BMP signaling. Biochem Biophys Res Commun. 2011;405:256\u201361.","journal-title":"Biochem Biophys Res Commun."},{"key":"3689_CR23","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nchembio.118","volume":"4","author":"AL Hopkins","year":"2008","unstructured":"Hopkins AL. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol. 2008;4:682\u201390.","journal-title":"Nat Chem Biol"},{"key":"3689_CR24","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk D, Gable AL, Nastou KC, Lyon D, Kirsch R, Pyysalo S, Doncheva NT, Legeay M, Fang T, Bork P, Jensen LJ, von Mering C. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res. 2021;49:D605\u201312.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"3689_CR25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2009","unstructured":"Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44\u201357.","journal-title":"Nat Protoc"},{"key":"3689_CR26","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/0471250953.bi0813s47","volume":"47","author":"G Su","year":"2014","unstructured":"Su G, Morris JH, Demchak B, Bader GD. Biological network exploration with Cytoscape 3. Curr Protoc Bioinformat. 2014;47:8\u201313.","journal-title":"Curr Protoc Bioinformat."},{"key":"3689_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1080\/21691401.2021.2020279","volume":"50","author":"G Ye","year":"2022","unstructured":"Ye G, Huang Y, Yin L, Wang J, Huang X, Bin X. Association between LEPR polymorphism and susceptibility of osteoporosis in Chinese Mulao people. Artif Cells Nanomed Biotechnol. 2022;50:10\u20136.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"3689_CR28","first-page":"1899","volume":"18","author":"YP Li","year":"2019","unstructured":"Li YP, Wu B, Liang J, Li F. Isopsoralen ameliorates H2O2-induced damage in osteoblasts via activating the Wnt\/\u03b2-catenin pathway. Exp Ther Med. 2019;18:1899\u2013906.","journal-title":"Exp Ther Med"},{"key":"3689_CR29","doi-asserted-by":"publisher","first-page":"117693432210750","DOI":"10.1177\/11769343221075014","volume":"18","author":"H Tang","year":"2022","unstructured":"Tang H, Han Q, Yin Y. Screening of Important markers in peripheral blood mononuclear cells to predict female osteoporosis risk using LASSO regression algorithm and SVM method. Evol Bioinform Online. 2022;18:11769343221075014.","journal-title":"Evol Bioinform Online"},{"key":"3689_CR30","doi-asserted-by":"publisher","first-page":"594785","DOI":"10.3389\/fcell.2020.594785","volume":"8","author":"Z Liu","year":"2020","unstructured":"Liu Z, Li C, Huang P, Hu F, Jiang M, Xu X, Li B, Deng L, Ye T, Guo L. CircHmbox1 targeting miRNA-1247-5p is involved in the regulation of bone metabolism by TNF-\u03b1 in postmenopausal osteoporosis. Front Cell Dev Biol. 2020;8:594785.","journal-title":"Front Cell Dev Biol"},{"key":"3689_CR31","doi-asserted-by":"publisher","first-page":"17370","DOI":"10.18632\/aging.203227","volume":"13","author":"P Cai","year":"2021","unstructured":"Cai P, Lu Y, Yin Z, Wang X, Zhou X, Li Z. Baicalein ameliorates osteoporosis via AKT\/FOXO1 signaling. Aging. 2021;13:17370\u20139.","journal-title":"Aging"},{"key":"3689_CR32","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1039\/D1FO02755G","volume":"13","author":"X Wang","year":"2022","unstructured":"Wang X, Tian Y, Liang X, Yin C, Huai Y, Zhao Y, Huang Q, Chu X, Wang W, Qian A. Bergamottin promotes osteoblast differentiation and bone formation via activating the Wnt\/\u03b2-catenin signaling pathway. Food Funct. 2022;13:2913\u201324.","journal-title":"Food Funct"},{"key":"3689_CR33","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1002\/jcb.23287","volume":"112","author":"GL Lin","year":"2011","unstructured":"Lin GL, Hankenson KD. Integration of BMP, Wnt, and notch signaling pathways in osteoblast differentiation. J Cell Biochem. 2011;112:3491\u2013501.","journal-title":"J Cell Biochem"},{"key":"3689_CR34","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jep.2009.01.026","volume":"122","author":"Y Wang","year":"2009","unstructured":"Wang Y, Cui K, Zhao H, Li D, Wang W, Zhu Y. Bushen Ningxin Decoction pharmacological serum promotes the proliferation and suppresses the apoptosis of murine osteoblasts through MAPK pathway. J Ethnopharmacol. 2009;122:221\u20136.","journal-title":"J Ethnopharmacol"},{"key":"3689_CR35","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s12011-018-1574-9","volume":"190","author":"H Zhou","year":"2019","unstructured":"Zhou H, Jiao G, Dong M, Chi H, Wang H, Wu W, Liu H, Ren S, Kong M, Li C, Zhang L, Chen Y. Orthosilicic acid accelerates bone formation in human osteoblast-like cells through the PI3K-Akt-mTOR pathway. Biol Trace Elem Res. 2019;190:327\u201335.","journal-title":"Biol Trace Elem Res"},{"key":"3689_CR36","doi-asserted-by":"publisher","first-page":"33361","DOI":"10.1074\/jbc.M205053200","volume":"277","author":"N Ghosh-Choudhury","year":"2002","unstructured":"Ghosh-Choudhury N, Abboud SL, Nishimura R, Celeste A, Mahimainathan L, Choudhury GG. Requirement of BMP-2-induced phosphatidylinositol 3-kinase and Akt serine\/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription. J Biol Chem. 2002;277:33361\u20138.","journal-title":"J Biol Chem"},{"key":"3689_CR37","doi-asserted-by":"publisher","first-page":"19146","DOI":"10.1074\/jbc.271.32.19146","volume":"271","author":"P Kaliman","year":"1996","unstructured":"Kaliman P, Vi\u00f1als F, Testar X, Palac\u00edn M, Zorzano A. Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells. J Biol Chem. 1996;271:19146\u201351.","journal-title":"J Biol Chem"},{"key":"3689_CR38","first-page":"6330","volume":"13","author":"X Ge","year":"2021","unstructured":"Ge X, Zhou G. Protective effects of naringin on glucocorticoid-induced osteoporosis through regulating the PI3K\/Akt\/mTOR signaling pathway. Am J Transl Res. 2021;13:6330\u201341.","journal-title":"Am J Transl Res"},{"key":"3689_CR39","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s11914-015-0264-1","volume":"13","author":"AD Bakker","year":"2015","unstructured":"Bakker AD, Jaspers RT. IL-6 and IGF-1 signaling within and between muscle and bone: How important is the mTOR pathway for bone metabolism? Curr Osteoporos Rep. 2015;13:131\u20139.","journal-title":"Curr Osteoporos Rep"},{"key":"3689_CR40","doi-asserted-by":"publisher","first-page":"274","DOI":"10.2174\/1871530321666210215161921","volume":"22","author":"MM Liu","year":"2021","unstructured":"Liu MM, Lv NN, Geng R, Hua Z, Ma Y, Huang GC, Cheng J, Xu HY. Uncovering the key miRNAs and targets of the Liuwei Dihuang pill in diabetic nephropathy-related osteoporosis based on weighted gene co-expression network and network pharmacology analysis. Endocr Metab Immune Disord Drug Targets. 2021;22:274\u201389.","journal-title":"Endocr Metab Immune Disord Drug Targets"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-023-03689-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-023-03689-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-023-03689-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T04:07:24Z","timestamp":1681704444000},"score":1,"resource":{"primary":{"URL":"https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-023-03689-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,17]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3689"],"URL":"https:\/\/doi.org\/10.1186\/s13018-023-03689-6","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,17]]},"assertion":[{"value":"10 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All\u00a0animal experiments are conducted in accordance with the ethical standards of Inner Mongolia People\u2019s Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could influence the work of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"304"}}